Ligand Pharmaceuticals, Inc. (LGND)
222.18
+4.43
(+2.03%)
USD |
NASDAQ |
May 21, 16:00
222.71
+0.53
(+0.24%)
After-Hours: 19:59
Ligand Pharmaceuticals Research and Development Expense (TTM) : 33.24M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 0.468M |
| Johnson & Johnson | 14.99B |
| Organon & Co. | 363.00M |
| Merck & Co., Inc. | 21.57B |
| Phathom Pharmaceuticals, Inc. | 31.37M |